Abbott Laboratories posted stronger-than-expected second-quarter profit and revenue results, even as demand for its Covid-19 testing products dropped when U.S. virus cases ebbed in the spring.
Abbott Laboratories posted stronger-than-expected second-quarter profit and revenue results, even as demand for its Covid-19 testing products dropped when U.S. virus cases ebbed in the spring.